Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Slow improvement in sales could weigh on pharma firm Laurus' performance
Company reported lower-than-expected revenue after missing target in key segment
Laurus is ready to flood US with cheap HIV drugs
US patents on key components for some important HIV therapies are set to expire starting in December and Laurus Labs is gearing up to cash in
